subject area of
- Agreements Between the Prothrombin Times of Blood Treated In Vitro with Heparinase During Cardiopulmonary Bypass (CPB) and Blood Sampled After CPB and Systemic Protamine Academic Article
- Anticoagulants and Their Reversal Academic Article
- Anti–protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis Academic Article
- Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery? Academic Article
- Comparative effects of heparin and LMW heparin on hemostasis Conference Paper
- Heparin and Low-Molecular-Weight Heparin Academic Article
- Heparin, DDAVP and the Bleeding Time Academic Article
- Investigation of the Anticoagulant Mechanisms of a Covalent Antithrombin-Heparin Complex Academic Article
- Management of intentional overdose of low-molecular-weight heparin Academic Article
- Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin Academic Article
- Neutralization of Enoxaparine-lnduced Bleeding by Protamine Sulfate Academic Article
- Randomized, Controlled Trial of Individualized Heparin and Protamine Management in Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass Academic Article
- Rivaroxaban for treatment of HIT: A riveting first experience Academic Article
- Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial Academic Article
- The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor Academic Article